The World Health Organization (WHO) utilized the term novel COVID-2019 to allude to an infection that influences the lower respiratory tract of patients who are suffering from pneumonia. On 29th December 2019, it was first turn up in the city of China named Wuhan. At present it is also referred as Middle East Respiratory Syndrome Coronavirus (MERS-CoV) and Severe Acute Respiratory Syndrome Coronavirus2 (SARS-CoV-2). Coronavirus is a RNA enveloped virus that is found in humans and wildlife. The base of virus was connected to a seafood market in Wuhan city. An aggregate of six animal categories has been distinguished to cause infection in humans. They are known to contaminate the neurological, respiratory, enteric, and hepatic frameworks. The flare-up was pronounced a public health emergency of international concern on 30th January 2020. It has been declared a pandemic by WHO on 11th March 2020 by WHO director general and is seen as a global emergency. There are no specific therapies approved by the U.S. Food and Drug Administration (FDA) yet, but several combinations of existing drugs are used as a supportive therapy. The objective of this review article is to provide key points related to clinical features, etiology, diagnosis, prevention, and treatment of COVID-19.
Select your language of interest to view the total content in your interested language
Der Pharma Chemica received 11575 citations as per Google Scholar report